Introduction
Two mechanisms play an important role in determining the outcome of a bacterial infection: the virulence of the strain and its resistance to antimicrobial agents.
First, it is important to know what virulence means.
Bacterial pathogenicity is defined as all the biochemical mechanisms that allow the microorganisms to cause infection [1] . Pathogenicity is a complex characteristic which depends on a large number of factors [2] , some related to the host and its immunity, and others related to the microorganism: infectious doses, virulence factors (adhesins, invasins, toxins, etc.), and resistance to the host defense mechanisms.
The word virulence is used to indicate the level of pathogenicity between different strains belonging to the same species, and is defined as the cell dose needed to cause a pathological response in the host. Thus, strains with differentlevelsofvirulencecanexistwithinthe samespecies.
Some of these virulence factors may be contained in chromosomal regions named pathogenicity islands (PAIs) which present several common characteristics. Some of these PAIs are unstable [3] . PAIs have been defined in Salmonella strains, uropathogenic Escherichia coli strains, Yersinia spp., Staphylococcus spp., and so on [3] . Other virulence factors are found in plasmids which have the capacity to transfer between strains belonging to the same or different species, favouring spread of virulence [4, 5] .
Currently, a large number of antimicrobial treatments are unsuccessful due to the increase in microorganisms resistant to the antimicrobial agents.
Bacteria can become resistant to antibiotics by two mechanisms: mutation and acquisition of new resistance genes. Mutation is a spontaneous mechanism that allows the creation of resistant subpopulation. For instance, mutations in the genes encoding DNA-gyrase and topoisomerase IV enzymes are the most frequent mechanism of quinolone resistance [7] .
Exposure of bacteria to antimicrobial agents results in the selection of resistant mutants which can acquire a high number of resistance genes. These genes are usually vertically transmitted but can also be horizontally transmitted by mobile genetic elements which play an important role in transference of resistance genes such as plasmids, phages, transposons, and gene cassettes [6, 8] . Acquisition of resistance may be associated with phenotypic changes in bacteria [9, 10] .
Relationship between resistance and virulence in Gram-negative microorganisms Salmonella spp. Horizontal transference of resistance genes is being studied by many research groups, due to the importance of this mechanism in antibiotic resistance between strains belonging to the same species or between strains belonging to different species which share the same ecological niche [11] . In recent years, transference of resistance genes together virulence genes has been found. This transference is carried out by plasmids called hybrid plasmids of resistance-virulence.
Salmonella enterica serotype Typhimurium is a zoonotic species that can acquire resistance genes from the environment [12] . Products of animal origin are important vectors for transferring antimicrobial resistance from animals to humans. S. typhimurium is one of the serotypes most frequently involved in animal and human salmonellosis. A high number of strains belonging to this serotype may be multiresistant to four or more antimicrobial agents [12] . In recent years, a lineage of this serotype, including strains with phagetypes DT104b, DT120, NRP (nonrecognized pattern), and nontypeable, characterized by presentation of the same phenotype of resistance (ampicillin/Amp, chloramphenicol/Chl, streptomycin/S, sulphadiazine/Sd, and tetracycline/Te) associated with a conjugative plasmid of about 140 kb, has been isolated in Spain [13] . This resistance profile is the same as that of the pandemic lineage DT104 but encoded by different genes, oxa1 (Amp), catA1 (Chl), aadA1a (S), sul1 (Sd), and tet(B) (Te). The oxa1 gene has only been found in this genomic group together with the aadA1a gene, both included in a class 1 integron associated with the Tn2603 transposon. These S. typhimurium strains do not have the serotype specific virulence plasmid (pLT90). However, they present a 140-kb transferable plasmid (pUO-StVR2) which contains resistance and virulence genes. Among the virulence genes, this plasmid contains the salmonella plasmid virulence (spv) genes that increase the growth rate of the bacteria in host cells and affect their interaction with the immune system and the rck gene that confers resistance to the complement system. In addition, the class 1 integron and catA1 and tet(B) resistance genes are found in this plasmid [5] . The pUO-StVR2 is a good example of the recombination-transposition process between plasmids which results in the generation of hybrid plasmids with resistance and virulence characteristics [13] .
A similar situation has been described in S. choleraesuis which presents the serovar-specific virulence plasmid pSCV of about 50 kb. Recombinant virulence plasmids have recently been found in this serotype ranging in size from 125 to 140 kb. These plasmids carry virulence and antibiotic resistance genes, notably sulI and bla TEM-1 encoding for resistance to sulphonamide and ampicillin, respectively [14] . The recombination of virulence plasmids with resistance plasmids provides Salmonella with not only the capacity to survive in an unfavourable drug environment but also the opportunity to form a new genetic lineage. In addition, this recombination may also extend the range of these plasmids and may, therefore, lead to the occurrence and spread of a more virulent resistant Salmonella [15] .
Carlson et al. [16] analysed over 400 multiresistant S. typhimurium isolates using an in-vitro tissue culture invasion assay to evaluate a potential relationship between antibiotic exposure and a hyperinvasive phenotype. Some isolates exhibited increases in invasion when were preexposed to certain antibiotics. However, they failed to identify any isolates that were hyperinvasive in the presence of any of the antibiotics evaluated. These results indicate that the hypervirulence of multiresistant S. typhimurium is not likely to occur at the level of invasion.
Escherichia coli
Several studies reported a relationship between the acquisition of antimicrobial and a decrease in virulence [17] [18] [19] .
Uropathogenic E. coli (UPEC) is the best example of this relationship. It is well known that these strains present virulence factors that allow them to colonize the urinary tract, to cause cystitis, pyelonephritis, prostatitis, and in severe cases, to reach the blood stream. Most of these virulence factors, such as haemolysin, cytotoxic necrotizing factor, P-fimbriae, siderophore systems, S-fimbriae, yersiniobactin, toxin autotransporters, and so on, are contained in PAIs [3] .
In recent years, an increase in quinolone resistance has been observed in E. coli [20, 21] possibly due to the use of these antimicrobial agents in the treatment of urinary tract infections. Velasco et al. [22] found that quinoloneresistant UPEC was less likely to produce invasive disease than quinolone-susceptible E. coli. These results were in agreement with a clinical study that found a lower proportion of quinolone-resistant E. coli in cases of pyelonephritis, renal abscesses, and bacteraemia [10] . Quinolone resistance seems to impair the capacity to invade renal and prostatic tissue but not to produce bacteraemia once local invasion has taken place. Clinical strains of UPEC causing cystitis, pyelonephritis and prostatitis have been analysed in order to study the different resistance and virulence profiles, and thereby to determine a relationship between the two characteristics. It is well known that bacterial isolates recovered from patients with pyelonephritis more frequently exhibit virulence factors, such as adhesins, than do isolates recovered from patients with cystitis [23, 24] .
Vila et al. [17] analysed 42 UPEC clinical isolates causing pyelonephritis and 58 isolates causing cystitis collected from women. The results obtained showed that quinolone-resistant isolates presented less type 1 fimbrial expression in comparison with quinolone-susceptible isolates (P ¼ 0.019). This result was similar to that obtained by Bagel et al. [9] who demonstrated that the percentage of nonfimbriated E. coli clinical isolates was higher among quinolone-resistant than quinolonesusceptible strains. It is important to know that type 1 fimbriae are mainly implicated in bladder colonization while P-fimbriae have a tropism for kidney [17] . In addition, haemolysin production is more frequent among isolates causing pyelonephritis than those causing cystitis [25] . Moreover, other virulence factors such as haemolysin, cnf1 and sat were more frequently found among quinolone-susceptible UPEC strains in comparison with quinolone-resistant strains [17] . In this study, quinoloneresistant UPEC presented fewer virulence factors and a decrease in type 1 fimbrial expression. Chromosomal virulence factors, such as aerobactin and P-fimbriae, are also less frequent among antimicrobial-resistant isolates [26] . Lo Bue et al. [27] observed that exposure to subMICs of ciprofloxacin inhibited fimbrial production in 79% of the E. coli strains studied. Other quinolones such as levofloxacin and ofloxacin also have effects on the adherence of UPEC strains [28] .
A possible explanation for these results could be:
(1) A mutation in codon 83 of DNA-gyrase produces quinolone resistance and a reduction in DNA supercoiling which is catalysed by this enzyme [29] . Expression of several virulence factors is related to negative supercoiling. This is the case of the fimA gene which encodes the FimA subunit of type 1 fimbriae [30, 31] , and the foc operon which encodes for F165, a P-like fimbriae [32] . (2) Exposure of bacteria to quinolones could increase the deletion and transposition of DNA regions such as PAIs. These PAIs present some characteristics of bacteriophage, and it has been demonstrated that prophages inserted in the chromosome are eliminated by SOS system activity. The SOS system is activated by quinolones, therefore, these antimicrobial agents contribute to the elimination of PAIs by a SOS-dependent pathway.
The first hypothesis does not exclude the second, and both mechanisms can be observed at the same time. In fact, in the study carried out by Vila et al. [17] , UPEC strains did not express type 1 fimbriae did not have the hly and cnf1 genes, both of which are associated with a PAI. These results were confirmed by Martínez-Martínez et al. [19] . They found less haemolytic capacity among UPEC quinolone-susceptible strains. The lack of haemolysis could be due to the loss of the gene or to a reduction in its expression.
That resistance to cotrimoxazole, neomycin, and tetracycline are less frequent among enterotoxigenic E. coli producing heat-labile toxin and haemolysin producer E. coli isolates collected from pigs with diarrhoea compared to those nonproducer ones has been demonstrated. However, these isolates more frequently present gentamicin resistance [33] . Vranes [34] analysed the effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin of the haemagglutination and adherence ability of P-fimbriated E. coli. Azithromycin damaged haemagglutination capacity, whereas ciprofloxacin and ceftazidime increased this capacity. On the contrary, all three antibiotics decreased the adherence of these strains to the cells. Gentamicin, penicillin, trimethoprim-sulfamethoxazole also have effects against adherence factors in UPEC [35] .
The question emerging from these results is: does the acquisition of resistance promote the loss of virulence factors, or does less virulence tend to make strains more resistant to antibiotics than those which are more virulent?
'In-vitro' studies using UPEC isolates have demonstrated that antimicrobial agents and, especially, quinolones induce the loss of virulence factors contained in PAIs in two ways: a partial SOS-dependent system loss, and a total non-SOS-dependent system loss [36] .
A relationship has been demonstrated between the presence of P-fimbriae and resistance to several antimicrobial agents in UPEC strains. In fact, strains displaying these fimbriae are more frequently resistant to tetracycline and carbenicillin than non-P-fimbriated strains. Moreover, all P-fimbriated strains are amoxicillin resistant. This relationship has been observed among UPEC strains belonging to different serogroups, suggesting the possibility that genes encoding P-fimbriae could be horizontally transferred [37] . On the contrary, some studies have reported that sub-MICs of ciprofloxacin increase their adhesiveness, and hence the risk of colonization by UPEC strains expressing mannose-resistant adhesins different from type P [38] . Kachroo [39] found an association between antimicrobial resistance and the expression of Dr adhesin among UPEC. They analysed 337 UPEC strains and found that only 12.4% expressed this adhesin. Interestingly, the UPEC strains expressing Dr adhesin had a high incidence of ampicillin resistance (83%), and only 17% of the Dr-bearing isolates studied were resistant to an ampicillin/sulbactam combination. Thus, treatment with ampicillin in combination with a beta-lactamase inhibitor could prevent the selective colonization by Dr adhesinbearing UPEC.
There are four recognized phylogenetic groups within E. coli and these have been designated A, B1, B2 and D.
Strains of the four groups differ in their phenotypic characteristics, including antibiotic resistance [40] . Phylogenetic groups A and B1 are more frequent in commensal strains, whereas B2 and D are more frequent in extra-intestinal strains. The distribution (absence/ presence) of a variety of genes thought to enable a strain to cause extra-intestinal disease also varies among strains of the four phylogenetic groups [41] .
Horcajada et al. [18] found that a relationship between antimicrobial resistance and virulence can be observed within a phylogenetic group. They analysed uropathogenic E. coli strains collected from patients with pyelonephritis that belonged to the B2 phylogenetic group, and found that nalidixic acid-resistant strains were less virulent than their susceptible counterparts.
Pseudomonas aeruginosa
Pseudomonas aeruginosa is an opportunistic pathogen which may cause pneumoniae and bacteraemia in an immunocompromised host [42] and is responsible for chronic destructive lung disease in patients with cystic fibrosis [43, 44] . One of the reasons for the prevalence of P. aeruginosa in the hospital setting might be its characteristically low susceptibility to antibiotics mainly due to the presence of several genes encoding multidrug resistance (MDR) efflux pumps in the genome of this species [45] . Four genetic efflux pump systems have been characterized for P. aeruginosa: MexAB-OprM system [46] ; MexCD-OprJ [47] ; MexEF-OprN [48] ; and MexXY [49] .
Different virulence factors are involved in the pathogenicity of P. aeruginosa. Some are cell associated (pili, nonpilus adhesins, lipopolysaccharide, and alginate) [50] , whereas others are secreted (proteases, rhamnolipids, exotoxin A, exoenzyme S, and pyocyanin) [51] . The production of many of these extracellular virulence factors is controlled by two cell-to-cell signalling systems (quorum sensing), called las and rhl [52] . In addition, P. aeruginosa can inject different exoproteins directly into the cell cytoplasm through a secretion mechanism named the type III secretion system (TTSS) which is well conserved in different bacterial pathogens [53] .
The connection between MDR and virulence factor production was first suggested in a study comparing multidrug-resistant P. aeruginosa clinical strains collected in a Japanese hospital. All multidrug-resistant strains were deficient in the production of pyocyanin, elastase, haemolysin, and casein protease, whereas susceptible strains produced these virulence factors [54] .
Several studies have shown that over-expression of some MDR efflux pumps are associated with virulence in P. aeruginosa. For instance, over-expression of the MexEFOprN efflux pump is correlated with a decrease in production of extracellular virulence factors [44] . In this study, it could be observed that after exposure to the quinolone norfloxacin, which over-expresses this efflux pump, a nfxC-mutant obtained from P. aeruginosa strain PAO4009 produced 20-fold less pyocyanin than the wildtype strain. Moreover, elastase activity was reduced more than 50%, and showed strongly reduced rhamnolipid production.
Linares et al. [45] showed that over-expression of MexEFOprN and MexCD-OprJ is associated with a reduction in the transcription of the TTSS genes leading to a reduction in bacterial cytotoxicity. In contrast, an over-expression of MexAB-OprM or MexXY did not produce any detectable effect on TTSS.
A case-control study revealed that patients infected with fluoroquinolone-resistant P. aeruginosa had more prolonged illness and higher mortality rates compared with patients infected with susceptible strains [55] . It is possible that fluoroquinolone resistance is associated with increased virulence due to enhancement of TTSS virulence [56] . More recently, Jeannot et al. [57] performed a study to investigate the effects of upregulation of the MexCD-OprJ efflux pump in the resistance and virulence of P. aeruginosa clinical isolates showing moderate resistance to ciprofloxacin. They found that MexCD-OprJ up-regulation correlated with an increased resistance to ciprofloxacin, cefepime, and chloramphenicol in most clinical strains. Furthermore, MexCD-OprJ up-regulation was found to impair bacterial growth and to have a strain-specific, variable impact on rhamnolipid, elastase, phospholipase C and pyocyanin production.
Relationship between resistance and virulence in Gram-positive microorganisms
Staphylococcus aureus
Staphylococcus aureus is the most common cause of hospital-acquired infection and significantly contributes to morbidity and mortality. The first methicillin-resistant S. aureus (MRSA) was found in 1960, 2 years after the therapeutic introduction of this antimicrobial agent. In only 30 years, MRSA strains have been found around the world. The incidence of MRSA as a cause of nosocomial infection is increasing in many countries [58] . The resistance profile of MRSA includes resistance to non-blactam antibiotics, reducing therapeutic options. MRSA can cause severe infections in hospitalized patients, especially amongst the immunocompromised, with serious consequences. The risk of acquiring MRSA is related to length of hospitalization, type of invasive diagnostic and therapeutic treatments, and the doses and length of antimicrobial treatment. It has been estimated that 12% of nosocomial infections are caused by S. aureus [58] .
The microorganism presents a variety of virulence factors, including invasion molecules, peptidoglycan in its cell wall, extracellular enzymes, and toxins. S. aureus has the capacity to produce a high number of extracellular products such as coagulase, leucocidin, haemolysin, enterotoxin, TSST-1, lipases, nucleases, and proteases. Strain virulence is the result of the sum of these biological factors. S. aureus is able to introduce itself in the tissues and to multiply locally in spite of the host immune system.
Recent studies [59] have demonstrated that the relative rate of mortality caused by MRSA bacteraemic infection is increased. This could be due to the high capacity of MRSA to spread to secondary locations. Patients with disseminated infection presented significantly higher mortality rates than patients without this type of infection or without infection. MRSA is more virulent than methicillin-susceptible S. aureus (MSSA), with the adherence factors allowing MRSA to cause infections in secondary locations being one of the most important differences.
The relationship between toxin production and susceptibility to mupirocin or other aminoglycosides has been studied in S. aureus [58] , with mupirocin-resistant MRSA being more frequently involved with acute or chronic infections than their susceptible counterparts possibly due to the inhibitory effect of mupirocin on isoleucine tRNA-synthetase. Stevens et al. [60] studied the effect of antibiotics on the expression of exotoxin genes in MSSA and MRSA. They found that sub-inhibitory concentrations of nafcillin induced and prolonged mRNA expression of Panton-Valentine leukocidin, a-toxin, and toxic-shock syndrome toxin, and increased toxin production. On the contrary, clindamycin and linezolid suppressed the translation, but not the transcription, of toxin genes.
That b-lactams are able to induce the SaeRS system in S. aureus, which is important for signal transduction in the pathogenicity of this microorganism rather than antimicrobial resistance has been demonstrated. SaeRS is a positive regulatory system for the expression of several virulence factors, such as coagulase, haemolysins, nuclease, and fibronectin-binding proteins [61] .
Streptococcus pneumoniae
Fuursted et al. [62] performed studies to determine the relationship between virulence and antimicrobial resistance in 10 isolates using penicillin G and six macrolides (erythromycin, azithromycin, clarithromycin, dirithromycin, roxithromycin, and spiramycin). This study was performed in immunocompetent mice by the intraperitoneal inoculation of virulent, penicillin-susceptible serotype 3 pneumococci which had been preexposed to penicillin G or a macrolide for 1 h. A significant decrease in the virulence of postantibiotic-phase pneumococci was induced only by erythromycin, azithromycin, dirithromycin, and spiramycin, displaying 5.9, 7.1, 4.2, and 3.6-fold increases in the 50% lethal dose (LD 50 ) compared to a control suspension, respectively. In a population-based study, Guillemot et al. [63] showed that a reduction in antibiotic use leads to substantially decreased rates of penicillin G-nonsusceptible S. pneumoniae (PNSP) carriage. Thus, when antibiotic exposure is reduced, antibiotic-susceptible strains develop a survival advantage and subsequently tend to once again become more dominant human colonizers.
Fluoroquinolone resistance in S. pneumoniae is primarily mediated by point mutations in the quinolone resistance-determining regions of the gyrA and parC genes. Johnson et al. [64] analysed two isogenic quinolone resistant S. pneumoniae (QRSP) double mutants and compared them the quinolone-susceptible S. pneumoniae (QSSP) parent EF3030. They found that strains containing the GyrA: Ser81-Phe, ParC: Ser79-Phe double mutations, which are frequently seen in clinical QRSP, competed poorly with EF3030 in competitive colonization or competitive lung infections. The strain containing the GyrA: Ser81-Phe, ParC: Ser79-Tyr double mutations, demonstrated reduced nasal colonization in competitive or noncompetitive lung infections. However, this strain was equally able to cause competitive or noncompetitive lung infection as well as EF3030.
Acquisition of b-lactam resistance was accompanied by a loss of virulence in S. pneumoniae due to an alteration of PBP 2b and 2x profiles [65] . However, quinolones did not have any effect in the virulence of this microorganism.
In conclusion, virulence and resistance are two closely related characteristics, and allow bacteria to avoid host defenses and antimicrobial treatment and, moreover, to cause more severe and chronic infections. This relationship warrants clinical attention particularly in patients in whom antibiotic therapy may be failing due to the emergence of resistant strains.
